At 34.1x trailing earnings and 26.3x forward earnings, the stock is not statistically cheap, especially with EPS expected to decline to 17.78 next year. The compression from a 34.1 P/E to 26.3 forward suggests the market anticipates normalization, but the absence of a PEG ratio and the elevated multiple relative to 9.60% ROE and 8.80% ROIC implies growth is not dramatically outpacing valuation. That said, an Altman Z-Score of 3.3 and a Current Ratio of 2.3 signal solid balance sheet stability, reducing bankruptcy risk and supporting cyclical durability. This is not a distressed value play; it is a financially sound industrial franchise priced for resilience rather than explosive growth, and any mispricing would hinge on whether margins hold at current levels.